lobbying_activities: 2505602
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2505602 | b53de053-e634-44d4-aa92-7e717dd24d32 | Q3 | TAUZIN CONSULTANTS, LLC | 400671007 | SORRENTO THERAPEUTICS, INC. | 2020 | third_quarter | MMM | Issues related to fair competition, the generic drug market, drug cost. Also issues related COVID-19. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2020-10-09T12:16:22.637000-04:00 |